Company / R&D per Share
Xenetic Biosciences, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.13
FY2025
5-year range
$0.20 / $3.15
FY2021-FY2025
Trend
-6.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.20 in FY2021 to $9.54 in FY2017.
Based on SEC 10-K filings.
2.13 in FY2025 with a 5-year CAGR of +21.5%.
Declined from $3.15 to $2.13 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +108.5%
- 5-Year CAGR
- +21.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 6.0% year-over-year.
- Peak r&d per share was recorded in FY2017.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.13 | -6.0% |
| FY2024 | $2.27 | -27.9% |
| FY2023 | $3.15 | +1236.4% |
| FY2022 | $0.24 | +18.9% |
| FY2021 | $0.20 | -75.4% |
| FY2020 | $0.81 | +69.5% |
| FY2019 | $0.48 | +2.1% |
| FY2018 | $0.47 | -95.1% |
| FY2017 | $9.54 | +1173.7% |
| FY2016 | $0.75 | +2812.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026